Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid.
Collado MC, Rautava S, Aakko J, Isolauri E, Salminen S. · 2016
Read Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid. by Collado MC, Rautava S, Aakko J, Isolauri E, Salminen S. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4802384.txt.
Introduction
Maria Carmen Collado and four co-authors challenge a textbook idea in Scientific Reports in 2016: that a baby's gut starts sterile and meets microbes first at birth. Early gut microbes program immune and metabolic health for years, so when the seeding starts matters. The team sampled fifteen mother-baby pairs, all full-term planned cesarean births, to keep collection clean.
Womb fluid and the placenta each carried a distinct microbe mix, sparse and low in variety, dominated by one broad group. Features of that mix matched the baby's first stool, hinting at transfer before birth. By three to four days old, the gut mix had shifted toward the microbes of first milk. The authors propose seeding begins before birth and continues through feeding.
Catalog record
| CREATOR | Collado MC, Rautava S, Aakko J, Isolauri E, Salminen S. |
|---|---|
| YEAR | 2016 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 46 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid By Maria Carmen Collado, Samuli Rautava, Juhani Aakko, Erika Isolauri, Seppo Salminen Published in: Scientific Reports DOI: 10.1038/srep23129 ABSTRACT Abstract Interaction with intestinal microbes in infancy has a profound impact on health and disease in later life through programming of immune and metabolic pathways. We collected maternal faeces, placenta, amniotic fluid, colostrum, meconium and infant faeces samples from 15 mother-infant pairs in an effort to rigorously investigate prenatal and neonatal microbial transfer and gut colonisation. To ensure sterile sampling, only deliveries at full term by elective caesarean section were studied. Microbiota composition and activity assessment by conventional bacterial culture, 16S rRNA gene pyrosequencing, quantitative PCR, and denaturing gradient gel electrophoresis revealed that the placenta and amniotic fluid harbour a distinct microbiota characterised by low richness, low diversity and the predominance of Proteobacteria. Shared features between the microbiota detected in the placenta and amniotic fluid and in infant meconium suggest microbial transfer at the foeto-maternal interface. At the age of 3–4 days, the infant gut microbiota composition begins to resemble that detected in colostrum. Based on these data, we propose that the stepwise microbial gut colonisation process may be initiated already prenatally by a distinct microbiota in the placenta and amniotic fluid. The link between the mother and the offspring is continued after birth by microbes present in breast milk. Recent scientific advances suggest that early gut microbiota perturbations and the ensuing aberrant immune and metabolic maturation act as a major contributing element in the development of non-communicable diseases and obesity1. Data from epidemiological studies link aberrant gut microbiota composition and factors known to disrupt intestinal microbial colonisation in early infancy with the development of disease in later life1. Delivery by caesarean section or early exposure to antibiotics and the resultant perturbation in the establishment of the gut microbiota have been associated with the development of asthma2,3,4, inflammatory bowel disease (IBD)2,5,6, and obesity7,8,9 in both epidemiological and experimental studies. The development of effective means to reduce disease risk by modulating early host-microbe interaction has been hindered by considerable gaps in our knowledge regarding the precise timing and origin of intestinal microbial colonisation. The presence of microbes in the healthy human placenta10,11, umbilical cord12, and meconium13,14,15 suggests that foetal microbial contact is a physiological phenomenon, but the significance of intrauterine microbes for infant gut colonisation remains to be elucidated. Both epidemiological studies and experimental data indicate, however, that foetal microbial contact may be causally related to disease risk. The maternal microbial environment16,17 and antibiotic exposure during pregnancy18 are both reportedly associated with the risk of developing asthma later in childhood. After birth, breast milk modulates the infant gut microbiota by providing factors, which selectively promote the growth of specific microbes such as bifidobacteria1,19. There are data to suggest that human mammary gland tissue harbours bacteria20 and it has been suggested, that microbes in breast milk may provide a repeating colonising inoculum to the neonatal gut21. We have previously reported a diverse microbiota in human colostrum reflecting the health and nutritional status of the mother21,22. Our current understanding of the role of intrauterine and breast milk bacteria in human gut colonisation is scarce. The purpose of this study was to characterise the microbial populations in the placenta, amniotic fluid and colostrum and to elucidate their role as the initial inoculum for the intestinal microbiota. The study is based on maternal faeces, placenta, amniotic fluid, colostrum, meconium and infant faeces samples obtained from mothers undergoing elective caesarean section delivery and their infants. Obtaining samples from several niches from the same mother-infant pairs and selecting only infants born by sterile elective caesarean section at full term without onset of labour, rupture of membranes or signs of maternal infection enabled us to reliably compare microbiota composition in these maternal compartments and correlate them with meconium and neonatal gut microbiota. The study design also allowed us to exclude the impact of bacterial transfer during vaginal delivery. We report here for the first time direct evidence suggesting that distinct amniotic fluid, placenta and colostrum microbiota contribute to perinatal human gut colonisation. RESULTS Distinct microbiota composition and activity in amniotic fluid, placenta, colostrum and meconium Altogether 15 mother-infant pairs from whom maternal faeces, placenta, amniotic fluid, colostrum, meconium and infant faeces samples were available for detailed microbiological analyses were included in the study (Table 1). All the neonates in the study were born by elective caesarean section at full term with no symptoms or signs of intrauterine infection. We found a unique microbial community in the placenta and amniotic fluid. Specific clustering of microbial findings clearly distinct from the maternal faecal microbiota was detected in these intrauterine compartments by both 16S rRNA gene pyrosequencing (Fig. 1A–C) PCR-DGGE methods (Fig. 1D). The microbes identified on family and genus levels in the different sample types are presented in Supplementary Tables 1 and 2. The activity of the amniotic fluid microbiota as assessed by functional assignment analyses of KEGG pathways was distinctly different from that observed in colostrum or meconium (Fig. 2A–C), both of which also exhibited a specific and unique microbiota composition (Fig. 1A–D). Our results thus corroborate the emerging notion of distinct microbiota in the amniotic cavity11, breast milk22, and meconium13,15. [Table: Clinical characteristics of the mothers and infants included in the study.] [Figure: Microbial community analysis of maternal faeces (M), placenta (PL), amniotic fluid (AF), colostrum (C), meconium (Me) and infant faeces (INF) samples.(A) Relative abundances of operational taxonomic units (OTUs) at phylum level. Relative abundances of OTUs accounting for >1% of the total bacterial community are shown for each sample. OTUs representing ≤1% are grouped as “other phylum”. (B) Diversity of the most abundant bacterial taxa identified at family level. Taxonomic assignment of 16S rRNA sequences was carried out by use of a naïve Bayesian classifier, the Ribosomal Database Project (RDP) Classifier with a cut-off 50% of homology. (C) Principal Coordinate Analysis (PCoA) plot based on the unweighted UniFrac distance matrix. Individual samples of maternal faeces (pink), placenta (yellow), amniotic fluid (red), colostrum (light blue), meconium (dark blue), and infant faeces (green) are shown as single points. Significant differences were reported between groups of samples (ANOSIM = 0.6805 & P = 0.001 with 999 permutations). (D) UPGMA Cluster analysis using Pearson similarity coefficient performed on PCR-DGGE analysis fingerprints from all samples. Maternal faeces (pink), placenta (yellow), amniotic fluid (red), colostrum (light blue), meconium (dark blue) and infant faeces (green) samples are shown as single pattern profiles. (E) Number of trimmed and filtered sequences obtained by 16S rRNA gene pyrosequencing. The numbers refer to individual mother-infant pairs. The horizontal line reflects the average number of sequences for all samples. (F) Alpha-diversity Box-whisker plots of taxa richness (Chao1 index) and diversity (Shannon-Wiener index) in samples analysed by 16S rRNA gene pyrosequencing. The letters above the bars indicate results of Tukey HSD test following a significant 1-way ANOVA. Mean values not sharing the same letters are significantly different from each other (p < 0.05). (G) Box-whisker plots Richness (Chao index) and diversity (Shannon index) of the microbiome in different sample types based on the PCR-DGGE fingerprints. The letters above the bars indicate results